MedTrace Logo

Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia

NCT02398838 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 622

Last updated 2015-04-06

No results posted yet for this study

Summary

This study examined the acceptability and feasibility of using a simplified regimen of medical abortion in the eastern and western regions of the country of Georgia. It was hypothesized that home use of mifepristone and buccal administration of misoprostol would be both acceptable and efficacious.

Conditions

  • Abortion, First Trimester

Interventions

DRUG

Home administration of 200 mg mifepristone

Home administration of 200 mg mifepristone.

DRUG

Home or clinic administration of 400 mcg buccal misoprostol

Home or clinic administration of 400 mcg buccal misoprostol

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02398838 on ClinicalTrials.gov